{"retracted":false,"update":{"timestamp":1400716800000,"doi":"10.1371/journal.pone.0098836","type":"correction"},"doi":"10.1371/journal.pone.0087746","journal":"PLoS ONE","publisher":"Public Library of Science (PLoS)","title":"Correction: Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study"}
